Leave no hit behind: accelerating lead molecule discovery against difficult targets
Thursday, April 1, 2021 2:20 PM to 2:40 PM · 20 min. (Africa/Abidjan)
Antibodies
Showcase
Presentation
Information
- Traditional hybridoma and phage display methods have failed to yield therapeutic antibodies against difficult targets like most GPCRs and ion channels
- This presentation will introduce Berkeley Lights’ new Opto™ Plasma B Discovery 4.0 workflow that enables recovery of 1000s of hits by screening up to 100,000 plasma B cells, down-selection of lead candidates by functional screening, and sequencing and re-expression of >1000 functionally-characterized antibodies … all in just 1 week
- By maximizing the diversity of antibodies through direct functional profiling of plasma B cells, the Opto Plasma B Discovery 4.0 workflow will allow users to tackle even the most challenging targets
John Proctor, Sr. Vice President, Antibody Therapeutics, Berkeley Lights